Results 111 to 120 of about 13,532 (284)

Clinical implications of imlifidase interference in antibody screening and transfusion management

open access: yesTransfusion, EarlyView.
Abstract Background Imlifidase has received conditional approval from the EMA for desensitizing deceased donor kidney transplant recipients. It works by cleaving IgG into F(ab′)2 and Fc fragments, thereby reducing the risk of antibody‐mediated rejection. However, its impact on diagnostic assays remains understudied. Case Report We present the case of a
Zgjim Osmani   +2 more
wiley   +1 more source

Reference Intervals of Selected Serum and Plasma Biochemical Analytes in Clinically Healthy Multiparous Holstein Cows During the Periparturient Period

open access: yesVeterinary Clinical Pathology, EarlyView.
ABSTRACT Background Monitoring the metabolic changes during the periparturient period is crucial. Objective We aimed to establish reference intervals (RIs) of several serum and plasma biochemical variables in multiparous periparturient Holstein dairy cows. Methods A total of 238 multiparous dry cows from six commercial dairy farms were enrolled.
Nektarios Siachos   +6 more
wiley   +1 more source

World Association for Veterinary Dermatology Consensus Statement for Diagnosis, and Evidence‐Based Clinical Practice Guidelines for Treatment and Prevention of Canine Leishmaniosis

open access: yesVeterinary Dermatology, EarlyView.
Hyperkeratosis of (a) the footpads and (b) the nasal planum. ABSTRACT Background Canine leishmaniosis (CanL) due to Leishmania infantum remains common, and veterinarians do not always follow scientifically sound approaches for diagnosis, treatment and prevention. Objectives To provide consensus guidelines for diagnosis and evidence‐based guidelines for
Manolis N. Saridomichelakis   +9 more
wiley   +1 more source

Gamma‐Glutamyl‐Cysteine Alleviates Inflammatory Bowel Disease by Suppressing the NF‐κB Pathway in Jejunum and Modulating the Gut Microbiota

open access: yeseFood, Volume 6, Issue 6, December 2025.
Gamma‐glutamyl‐cysteine (γ‐EC) has the potential to enhance the regulatory functions of the jejunal barrier by increasing the expression of tight junction proteins and inhibiting the expression of NF‐κB pathway proteins, and to alleviate inflammation by maintaining the level of intestinal short‐chain fatty acids through an increase in the population of
Shiyan Jian   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy